Q4 2024 STRATA Skin Sciences Inc Earnings Call Transcript
Key Points
- Strata Skin Sciences Inc (SSKN) reported a strong fourth quarter with a significant improvement in average net revenue per device, up 11% over the previous quarter and 6% over the prior year.
- The company's gross margin improved to 60%, showing a 480-basis point improvement over the prior year Q4.
- International sales were particularly strong, with a 27% increase over the third quarter and a 41% increase over Q4 2023, marking the highest level of international sales to date.
- The company successfully secured pre-authorization for over 3,700 acne patients in partner clinics, indicating strong adoption of their insurance-reimbursed treatments.
- Strata Skin Sciences Inc (SSKN) achieved a third consecutive quarter of sequential increase in gross domestic revenue billings, highlighting the effectiveness of their strategic efforts.
- The US extract install base declined from 923 to 864, indicating a reduction in the number of devices in operation.
- Total operating expenses for the fourth quarter of 2024 increased to $10 million from $8.2 million in the year-ago period.
- The company experienced a sequential decline of 22% between Q4 2023 and Q1 2024, reflecting a strong seasonal effect.
- Global net recurring revenue for the fourth quarter of 2024 was only slightly up at $5.8 million compared to $5.6 million in the fourth quarter of 2023.
- The company faces challenges in the Chinese and Korean markets due to economic changes and competitor bankruptcies, affecting local market distributors.
Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the STRATA Sciences Inc fourth quarter and year-end 2024 financial results and corporate update conference call. At this time, all participants are in a listen-only mode.
(Operator Instructions)
A webcast replay of the call will be available approximately one hour after the end of the call through May 13th, 2025. I would now like to turn the call over to Louis Toma of Core IR, the company's Investor Relations firm. Please go ahead, sir.
Thank you, operator. Good afternoon and thank you for participating in today's conference call. Earlier this afternoon, the company released its financial results for the quarter and year ended December 31, 2024. A copy of that press release can be found on the company's website at www.stratiksciences.com under the investors tab.
Joining me on today's earnings call from STRATA Skin Sciences
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
